Diseases, Conditions, Syndromes

Study reveals recommended anticoagulant therapy for COVID patients

The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalized with COVID-19, in a study published in the New England Journal of Medicine Evidence ...

Medications

COVID-19 drug Paxlovid may interact with common heart medications

Heart disease patients with symptomatic COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression to severe disease; however, it can interact with some previously prescribed medications. A review ...

page 2 from 23